Insider Shareholders with Direct Ownership of Soleno Therapeutics Inc (SLNO)
This section provides a comprehensive overview of the insiders with direct ownership of Soleno Therapeutics Inc (SLNO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SOLENO THERAPEUTICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bhatnagar Anish
CHIEF EXECUTIVE OFFICER |
1,807,954 | 1,274,910 | 577,076 $41.5 Million | 24 |
Mar 27, 2025
Reduced 25.66%
|
| 1,139,218 | 12,223 | 193,066 $13.9 Million | 11 |
Jun 06, 2024
Added 3.26%
|
|
|
James H Mackaness
CHIEF FINANCIAL OFFICER |
350,188 | 192,201 | 105,176 $7.57 Million | 24 |
Mar 27, 2025
Reduced 7.1%
|
|
Meredith Manning
Chief Commercial Officer |
90,600 | 45,249 | 45,351 $3.26 Million | 4 |
Mar 27, 2025
Reduced 44.93%
|
|
Michael F. Huang
Sr. VP of Clinical Development |
51,400 | 14,583 | 36,817 $2.65 Million | 4 |
Mar 27, 2025
Reduced 21.36%
|
| 203,085 | 185,073 | 28,143 $2.03 Million | 23 |
Mar 27, 2025
Reduced 45.48%
|
|
| 238,380 | 222,581 | 27,036 $1.95 Million | 26 |
Apr 01, 2025
Reduced 12.27%
|
|
| 112,719 | 33,567 | 15,401 $1.11 Million | 13 |
Jun 06, 2024
Added 29.68%
|
|
| 96,579 | 0 | 13,545 $975,104 | 7 |
Jun 06, 2024
Added 32.43%
|
|
| 13,000 | 0 | 13,000 $935,869 | 1 |
Aug 15, 2024
Added 50.0%
|
|
| 12,437 | 5,937 | 6,500 $467,934 | 3 |
Mar 28, 2025
Reduced 47.74%
|
|
| 6,500 | 0 | 6,500 $467,934 | 1 |
Jun 06, 2024
Added 50.0%
|